New hepatitis C therapies in clinical development

由 Vermehren Johannes, Sarrazin Christoph
出版 2011-07-01

New hepatitis C therapies in clinical development

由 Vermehren, Johannes, Sarrazin, Christoph
出版 2011

Colon capsule endoscopy: Current status and future directions

由 Tal, Andrea O, Vermehren, Johannes, Albert, Jörg G
發表在 World J Gastroenterol (2014)

Differences between Two Real-Time PCR-Based Hepatitis C Virus (HCV) Assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and One Signal Amplification Assay (Versant HCV RNA 3.0)...

由 Vermehren, Johannes, Kau, Annika, Gärtner, Barbara C., Göbel, Reinhild, Zeuzem, Stefan, Sarrazin, Christoph
出版 2008

A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers

由 Vermehren, Johannes, Lötsch, Jörn, Susser, Simone, Wicker, Sabine, Berger, Annemarie, Zeuzem, Stefan, Sarrazin, Christoph, Doehring, Alexandra
出版 2012

Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

由 Zitzer, Heike, Heilek, Gabrielle, Truchon, Karine, Susser, Simone, Vermehren, Johannes, Sizmann, Dorothea, Cobb, Bryan, Sarrazin, Christoph
出版 2013

Absence of HBV Reactivation in Patients With Resolved HBV Infection Following DAA Therapy for Hepatitis C: A 1-Year Follow-up Study

由 Mücke, Marcus M, Mücke, Victoria T, Peiffer, Kai-Henrik, Sarrazin, Christoph, Zeuzem, Stefan, Berger, Annemarie, Vermehren, Johannes
發表在 Open Forum Infect Dis (2018)

Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction

由 Tal, Andrea Oliver, Vermehren, Johannes, Friedrich-Rust, Mireen, Bojunga, Jörg, Sarrazin, Christoph, Zeuzem, Stefan, Trojan, Jörg, Albert, Jörg Gerhard
出版 2014

Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals

由 Finkelmeier, Fabian, Dultz, Georg, Peiffer, Kai-Henrik, Kronenberger, Bernd, Krauss, Franziska, Zeuzem, Stefan, Sarrazin, Christoph, Vermehren, Johannes, Waidmann, Oliver
發表在 Liver Cancer (2018)

Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix

由 Walter, Carmen, Oertel, Bruno G, Felden, Lisa, Kell, Christian A, Nöth, Ulrike, Vermehren, Johannes, Kaiser, Jochen, Deichmann, Ralf, Lötsch, Jörn
發表在 Neuropsychopharmacology (2016)

Development of a Second Version of the Cobas AmpliPrep/Cobas TaqMan Hepatitis C Virus Quantitative Test with Improved Genotype Inclusivity

由 Vermehren, Johannes, Colucci, Giuseppe, Gohl, Peter, Hamdi, Nabila, Abdelaziz, Ahmed Ihab, Karey, Ursula, Thamke, Diana, Zitzer, Heike, Zeuzem, Stefan, Sarrazin, Christoph
出版 2011

Liver transplantation for chronic hepatitis C virus infection in the United States 2002–2014: An analysis of the UNOS/OPTN registry

由 Dultz, Georg, Graubard, Barry I., Martin, Paul, Welker, Martin-Walter, Vermehren, Johannes, Zeuzem, Stefan, McGlynn, Katherine A., Welzel, Tania M.
發表在 PLoS One (2017)

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response

由 Cloherty, Gavin, Chevaliez, Stephane, Sarrazin, Christoph, Herman, Christine, Holzmayer, Vera, Dawson, George, Maasoumy, Benjamin, Vermehren, Johannes, Wedemeyer, Heiner, Feld, Jordan J., Pawlotsky, Jean-Michel
發表在 Sci Rep (2016)

Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms

由 Vermehren, Johannes, Stelzl, Evelyn, Maasoumy, Benjamin, Michel-Treil, Veronique, Berkowski, Caterina, Marins, Ed G., Paxinos, Ellen E., Marino, Enrique, Wedemeyer, Heiner, Sarrazin, Christoph, Kessler, Harald H.
發表在 J Clin Microbiol (2017)

Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms

由 Ferstl, Philip G, Müller, Mona, Filmann, Natalie, Hogardt, Michael, Kempf, Volkhard AJ, Wichelhaus, Thomas A, Lange, Christian M, Vermehren, Johannes, Zeuzem, Stefan, Reinheimer, Claudia, Waidmann, Oliver
發表在 Infect Drug Resist (2018)

Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis

由 Maasoumy, Benjamin, Hunyady, Bela, Calvaruso, Vincenza, Makara, Mihály, Vermehren, Johannes, Haragh, Attila, Susser, Simone, Bremer, Birgit, Cloherty, Gavin, Manns, Michael P., Craxì, Antonio, Wedemeyer, Heiner, Sarrazin, Christoph
發表在 PLoS One (2014)

Baseline MELD Score Predicts Hepatic Decompensation during Antiviral Therapy in Patients with Chronic Hepatitis C and Advanced Cirrhosis

由 Dultz, Georg, Seelhof, Martin, Herrmann, Eva, Welker, Martin-Walter, Friedrich-Rust, Mireen, Teuber, Gerlinde, Kronenberger, Bernd, von Wagner, Michael, Vermehren, Johannes, Sarrazin, Christoph, Zeuzem, Stefan, Hofmann, Wolf Peter
出版 2013

AFP ratio predicts HCC recurrence after liver transplantation

由 Koch, Christine, Bette, Theresa, Waidmann, Oliver, Filmann, Natalie, Schrecker, Christopher, Trojan, Jörg, Weiler, Nina, Vermehren, Johannes, Schnitzbauer, Andreas A., Bechstein, Wolf Otto, Zeuzem, Stefan, Herrmann, Eva, Welker, Martin-Walter
發表在 PLoS One (2020)

Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers

由 Vermehren, Johannes, Vermehren, Annika, Mueller, Axel, Carlebach, Amina, Lutz, Thomas, Gute, Peter, Knecht, Gaby, Sarrazin, Christoph, Friedrich-Rust, Mireen, Forestier, Nicole, Poynard, Thierry, Zeuzem, Stefan, Herrmann, Eva, Hofmann, Wolf Peter
出版 2012

Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

由 Finkelmeier, Fabian, Canli, Özge, Peiffer, Kai-Henrik, Walter, Dirk, Tal, Andrea, Koch, Christine, Pession, Ursula, Vermehren, Johannes, Trojan, Jörg, Zeuzem, Stefan, Piiper, Albrecht, Greten, Florian R., Grammatikos, Georgios, Waidmann, Oliver
發表在 PLoS One (2018)